Recruiting Essential Tremor Studies in Omaha
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies evaluating pirtobrutinib....
A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease
This study is being done to see if adding GLIADEL to the site where the tumor was removed works as well as just having the tumor removed with radiation treatment done within six weeks after the surger...
About Essential Tremor Clinical Trials in Omaha
Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.
There are currently 2 essential tremor clinical trials recruiting participants in Omaha, NE. These studies are seeking a combined 887 participants. Research is being sponsored by Eli Lilly and Company, University of Nebraska. Clinical trial participation is free and participants receive study-related medical care at no cost.
Essential Tremor Clinical Trials in Omaha — FAQ
Are there essential tremor clinical trials in Omaha?
Yes, there are 2 essential tremor clinical trials currently recruiting in Omaha, NE. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Omaha?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Omaha research site will contact you about next steps.
Are clinical trials in Omaha free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Omaha studies also compensate for your time and travel.
What essential tremor treatments are being tested?
The 2 active trials in Omaha are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.
Data updated March 2, 2026 from ClinicalTrials.gov